|
|
Home | Submit Press Release | Advertise | Submit Website
(CityRegions.Com, October 05, 2017 ) Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli
Scope of the Report:
This report focuses on the Procalcitonin Antibody in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, Southeast Asia, India and Australia. This report categorizes the market based on manufacturers, countries/Regions, type and application.
Request a sample Report
Market Segment by Manufacturers, this report covers
Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
Wondfo
Ningbo Medicalsystem Biotechnology
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Shanghai Medicine'nest Pharmaceutical
Kitgen
Beijing KeyGen
Fantibody
Market Segment by Countries, covering
China
Japan
Korea
Taiwan
Southeast Asia
India
Australia
Market Segment by Type, covers
Polyclonal Procalcitonin Antibody
Monoclonal Procalcitonin Antibody
Market Segment by Applications, can be divided into
Hospital
Medical research institutions
Others
There are 19 Chapters to deeply display the Asia-Pacific Procalcitonin Antibody market.
Chapter 1, to describe Procalcitonin Antibody Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Procalcitonin Antibody, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the Asia-Pacific market by countries, covering China, Japan, Korea, Southeast Asia, Taiwan, India and Australia, with sales, price, revenue and market share of Procalcitonin Antibody, for each country, from 2012 to 2017;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;
Chapter 7, 8, 9, 10, 11, 12 and 13 to analyze the key countries by manufacturers, Type and Application,covering China,Japan,Korea,Southeast Asia, Taiwan, India and Australia,with sales,revenue and market share by manufacturers,types and application;
Chapter 14, Procalcitonin Antibody market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022;
Chapter 15, to analyze the manufacturing cost, key raw materials and manufacturing process etc.
Chapter 16, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 17, to describe sales channel, distributors, traders, dealers etc.
Chapter 18 and 19, to describe the research findings and conclusion, appendix, methodology and data source
View Full Report
Worldwide Market Reports
Pareesh Phulkar
+1-415 871 0703
sales@worldwidemarketreports.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
